Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
-17.44%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$39.3B
AUM Growth
-$8.33B
(-17%)
Cap. Flow
+$1.43B
Cap. Flow
% of AUM
3.65%
Top 10 Holdings %
Top 10 Hldgs %
21.56%
Holding
2,506
New
931
Increased
843
Reduced
589
Closed
109
Top Buys
| 1 |
Apple
AAPL
|
$210M |
| 2 |
Microsoft
MSFT
|
$179M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
$167M |
| 4 |
Amazon
AMZN
|
$118M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
$111M |
Top Sells
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
$404M |
| 2 |
MIME
Mimecast Limited
MIME
|
$108M |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$73.3M |
| 4 |
Albemarle
ALB
|
$66.9M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$62.7M |
Sector Composition
| 1 | Technology | 27.08% |
| 2 | Industrials | 10.04% |
| 3 | Consumer Discretionary | 8.09% |
| 4 | Energy | 7.43% |
| 5 | Materials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDNY
2101
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $229K | ﹤0.01% |
+13,134
| New | +$229K |
|
2102
Brixmor Property Group
BRX
$8.63B
| $228K | ﹤0.01% |
11,263
+864
| +8% | +$17.5K |
|
2103
Aclaris Therapeutics
ACRS
$227M
| $227K | ﹤0.01% |
+16,245
| New | +$227K |
|
2104
Horizon Bancorp
HBNC
$853M
| $227K | ﹤0.01% |
+13,024
| New | +$227K |
|
2105
News Corp Class B
NWS
$18.8B
| $227K | ﹤0.01% |
14,324
+3,690
| +35% | +$58.5K |
|
2106
Mirion Technologies
MIR
$5.28B
| $226K | ﹤0.01% |
+39,188
| New | +$226K |
|
2107
PureCycle Technologies
PCT
$2.41B
| $226K | ﹤0.01% |
+30,398
| New | +$226K |
|
2108
eXp World Holdings
EXPI
$1.76B
| $225K | ﹤0.01% |
+19,059
| New | +$225K |
|
|
GMRE
2109
Global Medical REIT
GMRE
$508M
| $224K | ﹤0.01% |
+20,044
| New | +$224K |
|
2110
Unisys
UIS
$277M
| $224K | ﹤0.01% |
+18,650
| New | +$224K |
|
2111
Harmonic Inc
HLIT
$1.14B
| $223K | ﹤0.01% |
+25,737
| New | +$223K |
|
2112
Eventbrite
EB
$254M
| $222K | ﹤0.01% |
+21,634
| New | +$222K |
|
2113
The GEO Group
GEO
$2.92B
| $222K | ﹤0.01% |
+33,570
| New | +$222K |
|
2114
Pennant Group
PNTG
$840M
| $222K | ﹤0.01% |
+17,364
| New | +$222K |
|
2115
TeraWulf
WULF
$3.58B
| $222K | ﹤0.01% |
+185,033
| New | +$222K |
|
2116
Alphatec Holdings
ATEC
$2.43B
| $219K | ﹤0.01% |
+33,477
| New | +$219K |
|
|
HA
2117
DELISTED
Hawaiian Holdings, Inc.
HA
| $219K | ﹤0.01% |
+15,320
| New | +$219K |
|
2118
Artivion
AORT
$2.05B
| $218K | ﹤0.01% |
+11,565
| New | +$218K |
|
2119
EchoStar
SATS
$19.3B
| $218K | ﹤0.01% |
+11,303
| New | +$218K |
|
|
SUPV
2120
Grupo Supervielle
SUPV
$701M
| $218K | ﹤0.01% |
160,123
+17,444
| +12% | +$23.7K |
|
2121
Veru
VERU
$49.4M
| $218K | ﹤0.01% |
+1,928
| New | +$218K |
|
2122
Kymera Therapeutics
KYMR
$3.11B
| $217K | ﹤0.01% |
+11,017
| New | +$217K |
|
2123
Health Catalyst
HCAT
$238M
| $216K | ﹤0.01% |
+14,920
| New | +$216K |
|
2124
E.W. Scripps
SSP
$261M
| $216K | ﹤0.01% |
+17,286
| New | +$216K |
|
|
EDN
2125
Edenor
EDN
$957M
| $215K | ﹤0.01% |
49,419
+5,337
| +12% | +$23.2K |
|